Mario Falsaperla
Overview
Explore the profile of Mario Falsaperla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carilli M, Iacovelli V, Signoretti M, Pastore A, Gaboardi F, Pini G, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518002
Objectives: A radiation-induced ureteral stricture (RIUS) is a challenging condition in urologic surgery, and the optimal surgical strategy is still a matter of debate. The aim of this study was...
2.
Volpe A, Capitanio U, Falsaperla M, Giannarini G, Palumbo C, Antonelli A, et al.
Minerva Urol Nephrol
. 2024 Mar;
76(1):9-21.
PMID: 38426419
Introduction: Partial nephrectomy (PN) aims to remove renal tumors while preserving renal function without affecting oncological and perioperative surgical outcomes. Aim of this paper is to summarize the current evidence...
3.
Bertolo R, Bove P, Sandri M, Celia A, Cindolo L, Cipriani C, et al.
Eur Urol Open Sci
. 2022 Dec;
46:75-81.
PMID: 36506251
Background: Recent randomized trials (RCTs) in the field of robotic partial nephrectomy (PN) showed no significant differences in perioperative outcomes between the off- and on-clamp approaches. Objective: To compare the...
4.
Ornaghi P, Porreca A, Sandri M, Sciarra A, Falsaperla M, Ludovico G, et al.
Prostate Cancer Prostatic Dis
. 2022 Jul;
26(4):730-735.
PMID: 35869394
Background: Evidence on clinical presentation of benign prostatic hyperplasia (BPH) is scarce, and studies involving outpatients are lacking. We aimed to provide an insight into the contemporary Italian scenario of...
5.
Bertolo R, Bove P, Sandri M, Cindolo L, Annino F, Leonardo C, et al.
Minerva Urol Nephrol
. 2022 Mar;
74(1):5-10.
PMID: 35272452
No abstract available.
6.
Cacciamani G, Sholklapper T, Delloglio P, Rocco B, Annino F, Antonelli A, et al.
Eur Urol Focus
. 2022 Feb;
8(6):1847-1858.
PMID: 35177353
Background: Intraoperative adverse events (iAEs) are surgical and anesthesiologic complications. Despite the availability of grading criteria, iAEs are infrequently reported in the surgical literature and in cases for which iAEs...
7.
Pennisi I, Giordano G, Lentini V, Meo D, Piana S, Falsaperla M, et al.
Radiol Case Rep
. 2022 Jan;
17(3):875-877.
PMID: 35059091
True ureteral metastases from gastric cancer are extremely rare. Only a few cases of this condition have been reported. CT is the first-line imaging technique and may aid the diagnosis,...
8.
Minervini A, Di Maida F, Mari A, Porreca A, Rocco B, Celia A, et al.
Cent European J Urol
. 2021 Aug;
74(2):259-268.
PMID: 34336248
Introduction: The aim of this study was to assess the safety of elective urological surgery performed during the pandemic by estimating the prevalence of COVID-19-like symptoms in the postoperative period...
9.
De Nunzio C, Lombardo R, Baldassarri V, Cindolo L, Bertolo R, Minervini A, et al.
Eur J Surg Oncol
. 2021 May;
47(10):2640-2645.
PMID: 33965292
Objectives: The Rotterdam Prostate Cancer Risk calculator (RPCRC) has been validated in the past years. Recently a new version including multiparametric magnetic resonance imaging (mpMRI) data has been released. The...
10.
Bove P, Bertolo R, Sandri M, Cipriani C, Leonardo C, Parma P, et al.
J Urol
. 2020 Dec;
205(3):685.
PMID: 33355504
No abstract available.